Natural Alternatives International (NAII) 10-Q 9 Feb 21 2021 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2020	Feb. 09, 2021
Document Information [Line Items]
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Entity Central Index Key	0000787253
Trading Symbol	naii
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		2,529,005
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false
Title of 12(b) Security	Common Stock, $0.01 par value per share

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Current assets:
Cash and cash equivalents	$ 28,629	$ 30,478
Accounts receivable - less allowance for doubtful accounts of $3,185 at December 31, 2020 and $3,240 at June 30, 2020	17,062	17,001
Inventories, net	34,466	27,972
Income tax receivable	200	848
Forward contracts		450
Prepaids and other current assets	3,060	2,275
Total current assets	83,417	79,024
Property and equipment, net	22,409	21,523
Operating lease right-of-use assets	17,034	18,354
Deferred tax asset – noncurrent	1,262	196
Other noncurrent assets, net	1,397	1,106
Total assets	125,519	120,203
Current liabilities:
Accounts payable	12,377	12,509
Accrued liabilities	2,809	1,627
Accrued compensation and employee benefits	2,330	2,660
Forward contracts	3,184
Income taxes payable	1,988	1,010
Lines of credit – current	10,000	10,000
Total current liabilities	32,688	27,806
Long-term liability – operating leases	17,956	18,782
Noncurrent forward contracts	403	195
Long-term pension liability	734	696
Income taxes payable, noncurrent	1,250	1,349
Total liabilities	53,031	48,828
Commitments and contingencies (Note L)
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized; issued and outstanding (net of treasury shares) 6,363,865 at December 31, 2020 and 6,752,372 at June 30, 2020	88	87
Additional paid-in capital	28,689	27,992
Retained earnings	62,071	56,181
Treasury stock, at cost, 2,523,254 shares at December 31, 2020 and 2,104,305 June 30, 2020	(15,203)	(11,702)
Accumulated other comprehensive loss	(3,157)	(1,183)
Total stockholders’ equity	72,488	71,375
Total liabilities and stockholders’ equity	$ 125,519	$ 120,203

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Accounts receivable, allowance for doubtful accounts	$ 3,185	$ 3,240
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares outstanding (in shares)	6,363,865	6,752,372
Treasury stock, shares (in shares)	2,523,254	2,104,305

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net sales	$ 48,083	$ 29,103	$ 87,809	$ 58,298
Cost of goods sold	38,409	24,042	72,130	48,853
Gross profit	9,674	5,061	15,679	9,445
Selling, general and administrative	4,282	4,363	8,202	8,802
Income from operations	5,392	698	7,477	643
Other (expense) income:
Interest income	1	50	1	129
Interest expense	(49)	(7)	(95)	(11)
Foreign exchange loss	(753)	(162)	(1,018)	(53)
Other, net	(5)	(5)	(15)	(12)
Total other (expense) income	(806)	(124)	(1,127)	53
Income before income taxes	4,586	574	6,350	696
Provision for income taxes	954	98	460	124
Net income	3,632	476	5,890	572
Unrealized loss resulting from change in fair value of derivative instruments, net of tax	(854)	(903)	(1,974)	(516)
Comprehensive income (loss)	$ 2,778	$ (427)	$ 3,916	$ 56
Net income per common share:
Basic (in dollars per share)	$ 0.58	$ 0.07	$ 0.93	$ 0.08
Diluted (in dollars per share)	$ 0.57	$ 0.07	$ 0.91	$ 0.08
Weighted average common shares outstanding
Basic (in shares)	6,270,419	6,795,269	6,344,256	6,818,249
Diluted (in shares)	6,405,308	6,885,934	6,438,143	6,935,580

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member]Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]Treasury Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Jun. 30, 2019							8,851,677			1,626,605
Balance (Accounting Standards Update 2016-02 [Member]) at Jun. 30, 2019			$ 420			$ 420
Balance at Jun. 30, 2019							$ 87	$ 26,280	$ 57,380	$ (7,955)	$ 292	$ 76,084
Repurchase of common stock (in shares)										159,668
Repurchase of common stock										$ (1,332)		$ (1,332)
Issuance of common stock for stock option exercise (in shares)												0
Issuance of common stock for stock option exercise
Unrealized loss resulting from change in fair value of derivative instruments, net of tax											(516)	(516)
Net income									572			572
Issuance of common stock for restricted stock grants (in shares)							5,000
Issuance of common stock for restricted stock grants
Compensation expense related to stock compensation plans								892				892
Balance (in shares) at Dec. 31, 2019							8,856,677			1,801,273
Balance at Dec. 31, 2019							$ 87	27,172	58,500	$ (9,287)	(352)	76,120
Forfeiture of restricted stock (in shares)										15,000
Forfeiture of restricted stock
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect									128		(128)
Balance (in shares) at Sep. 30, 2019							8,851,677			1,643,322
Balance at Sep. 30, 2019							$ 87	26,713	58,024	$ (7,970)	551	77,405
Repurchase of common stock (in shares)										157,951
Repurchase of common stock										$ (1,317)		$ (1,317)
Issuance of common stock for stock option exercise (in shares)												0
Unrealized loss resulting from change in fair value of derivative instruments, net of tax											(903)	$ (903)
Net income									476			476
Issuance of common stock for restricted stock grants (in shares)							5,000
Issuance of common stock for restricted stock grants
Compensation expense related to stock compensation plans								459				459
Balance (in shares) at Dec. 31, 2019							8,856,677			1,801,273
Balance at Dec. 31, 2019							$ 87	27,172	58,500	$ (9,287)	(352)	76,120
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect
Balance (in shares) at Jun. 30, 2020							8,856,677			2,104,305
Balance at Jun. 30, 2020							$ 87	27,992	56,181	$ (11,702)	(1,183)	71,375
Compensation expense related to stock compensation plans								698				698
Repurchase of common stock (in shares)										418,949
Repurchase of common stock										$ (3,501)		$ (3,501)
Issuance of common stock for stock option exercise (in shares)							30,442					100,000
Issuance of common stock for stock option exercise							$ 1	(1)
Unrealized loss resulting from change in fair value of derivative instruments, net of tax											(1,974)	(1,974)
Net income									5,890			5,890
Balance (in shares) at Dec. 31, 2020							8,887,119			2,523,254
Balance at Dec. 31, 2020							$ 88	28,689	62,071	$ (15,203)	(3,157)	72,488
Balance (in shares) at Sep. 30, 2020							8,856,677			2,340,387
Balance at Sep. 30, 2020							$ 87	28,353	58,439	$ (13,445)	(2,303)	71,131
Compensation expense related to stock compensation plans								337				337
Repurchase of common stock (in shares)										182,867
Repurchase of common stock										$ (1,758)		$ (1,758)
Issuance of common stock for stock option exercise (in shares)							30,442					100,000
Issuance of common stock for stock option exercise							$ 1	(1)
Unrealized loss resulting from change in fair value of derivative instruments, net of tax											(854)	(854)
Net income									3,632			3,632
Balance (in shares) at Dec. 31, 2020							8,887,119			2,523,254
Balance at Dec. 31, 2020							$ 88	$ 28,689	$ 62,071	$ (15,203)	$ (3,157)	$ 72,488

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net income	$ 5,890	$ 572
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,148	1,966
Non-cash compensation	698	892
Non-cash lease expenses	494	96
Deferred income taxes	(469)
(Gain) loss on disposal of assets	(3)	122
Pension expense, net of contributions	38	9
Changes in operating assets and liabilities:
Accounts receivable, net	(61)	1,737
Inventories, net	(6,494)	3,353
Prepaids and other assets	(1,075)	(602)
Accounts payable and accrued liabilities	1,050	(2,687)
Forward contracts	1,270	(10)
Accrued compensation and employee benefits	(330)	(733)
Income taxes	1,527	93
Net cash provided by operating activities	4,683	4,808
Cash flows from investing activities
Purchases of property and equipment	(3,034)	(1,633)
Proceeds from sale of property and equipment	3	17
Net cash used in investing activities	(3,031)	(1,616)
Cash flows from financing activities
Repurchase of common stock	(3,501)	(1,332)
Net cash used in financing activities	(3,501)	(1,332)
Net (decrease) increase in cash and cash equivalents	(1,849)	1,860
Cash and cash equivalents at beginning of period	30,478	25,040
Cash and cash equivalents at end of period	28,629	26,900
Supplemental disclosures of cash flow information
Interest	91	11
Taxes	$ 263	$ 18

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 six December 31, 2020 not You should read the financial statements and these notes, which notes are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 2020 ( “2020 2020 Recently Adopted Accounting Pronouncements We did not three six December 31, 2020. Recently Issued Accounting and Regulatory Pronouncements In November 2020, No. 33 10825, 101, 103, 105, Other recently issued accounting pronouncements are not not not Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options and unvested restricted shares account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2020 2019 2020 2019 Numerator Net income $ 3,632 $ 476 $ 5,890 $ 572 Denominator Basic weighted average common shares outstanding 6,270 6,795 6,344 6,818 Dilutive effect of stock options and restricted stock 135 91 94 117 Diluted weighted average common shares outstanding 6,405 6,886 6,438 6,935 Basic net income per common share $ 0.58 $ 0.07 $ 0.93 $ 0.08 Diluted net income per common share $ 0.57 $ 0.07 $ 0.91 $ 0.08 We did not three December 31, 2020. six December 31, 2020 90,000 116,658 not three six December 31, 2019 none Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligations is fulfilled, and control of ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will continue to take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price of customer contracts. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2020, no We have an Exclusive Manufacturing Agreement with Juice Plus+, as amended and restated on March 31, 2019, ( 24 August 6, 2025. $0.4 three December 31, 2020 $0.8 six December 31, 2020. $0.4 three December 31, 2019 $0.8 six December 31, 2019. We currently own certain U.S. patents, and each such patent's corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as “beta-alanine”, which we market and sell under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $2.8 three December 31, 2020 $5.4 six December 31, 2020. $4.3 three December 31, 2019 $7.5 six December 31, 2019. $0.1 three December 31, 2020 $0.3 six December 31, 2020. $0.2 three December 31, 2019 $0.4 six December 31, 2019. Stock-Based Compensation We had an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 October 15, 2019. January 1, 2021 ( “2020 December 4, 2020. 2020 may We did not three six December 31, 2020 December 31, 2019. three six December 31, 2020, 100,000 30,442 No three six December 31, 2019. no three six December 31, 2020 December 31, 2019. We did not three six December 31, 2020. three six December 31, 2019, 5,000 No three six December 31, 2020. three December 31, 2019, no six December 31, 2019, 15,000 $0.3 three December 31, 2020 $0.7 six December 31, 2020. $0.5 three December 31, 2019, $0.9 six December 31, 2019. Deferred Compensation Plan Effective July 16, 2020, may The Incentive Plan authorizes the Human Resources Committee or the Board of Directors to grant to, and administer, unsecured and deferred cash Awards to Participants and to subject each Award to whatever conditions are determined appropriate by the Human Resources Committee or the Board of Directors. The terms of each Award, including the amount and any conditions that must be met to be entitled to payment of the Award are set forth in an Award Agreement between each Participant and NAI. The Incentive Plan provides the Board of Directors with the discretion to set aside assets to fund the Incentive Plan although that has not On July 16, 2020, $1.0 three one two three no Fair Value of Financial Instruments Except for cash and cash equivalents, as of December 31, 2020 June 30, 2020, not 1. We classify derivative forward exchange contracts as Level 2 December 31, 2020 $3.6 third We also classify our outstanding line of credit balance as a Level 2 December 31, 2020, June 30, 2020, not 3. We did not three six December 31, 2020 three six December 31, 2019. COVID- 19 We continue to monitor and evaluate the risks to public health and the impact on overall global business activity related to the COVID- 19 may

Note B - Inventories, Net

Note B - Inventories, Net	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): Dec ember 3 1 , 2020 June 30, 20 20 Raw materials $ 22,531 $ 20,863 Work in progress 5,000 3,447 Finished goods 7,663 4,936 Reserve (728 ) (1,274 ) $ 34,466 $ 27,972 The inventory reserve includes $0.5 December 31, 2020 $1.0 June 30, 2020 one three December 31, 2020, $0.3 six December 31, 2020, $0.5

Note C - Property and Equipment

Note C - Property and Equipment	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life In Years Dec ember 3 1 , 2020 June 30, 2020 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,748 3,743 Machinery and equipment 3 – 12 36,244 33,405 Office equipment and furniture 3 – 5 5,388 5,318 Vehicles 3 255 255 Leasehold improvements 1 – 15 18,151 18,031 Total property and equipment 64,986 61,952 Less: accumulated depreciation and amortization (42,577 ) (40,429 ) Property and equipment, net $ 22,409 $ 21,523

Note D - Other Comprehensive Lo

Note D - Other Comprehensive Loss	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Other Comprehensive Loss Other comprehensive (loss) income (“OCL” and “OCI”) consisted of the following during the three six December 31, 2020 December 31, 2019 ( Three Months Ended Six Months Ended December 31, 2020 December 31, 2020 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (888 ) $ (1,415 ) $ (2,303 ) $ (888 ) $ (295 ) $ (1,183 ) OCI/OCL before reclassifications - (1,850 ) (1,850 ) - (3,913 ) (3,913 ) Amounts reclassified from OCI - 737 737 - 1,341 1,341 Tax effect of OCI activity - 259 259 - 598 598 Net current period OCI/OCL - (854 ) (854 ) - (1,974 ) (1,974 ) Ending Balance $ (888 ) $ (2,269 ) $ (3,157 ) $ (888 ) $ (2,269 ) $ (3,157 ) Three Months Ended Six Months Ended December 31, 2019 December 31, 2019 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (565 ) $ 1,116 $ 551 $ (491 ) $ 783 $ 292 ASU 2018-02 Adjustment - - - (74 ) (54 ) (128 ) OCI/OCL before reclassifications - (369 ) (369 ) - 932 932 Amounts reclassified from OCI - (808 ) (808 ) - (1,612 ) (1,612 ) Tax effect of OCI activity - 274 274 - 164 164 Net current period OCI/OCL - (903 ) (903 ) (74 ) (570 ) (644 ) Ending Balance $ (565 ) $ 213 $ (352 ) $ (565 ) $ 213 $ (352 ) ASU 2018 02, Income Statement-Reporting Comprehensive Income (Topic 220 2017 $0.1 six December 30, 2019.

Note E - Leases

Note E - Leases	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	E. Leases On July 1, 2019, 842, Leases 842, 842, July 1, 2019, 842, 842 840. no We adopted ASC 842 July 1, 2019. 842 840 842, $20.7 $20.9 840, July 1, 2019, 842, not 1 2 3 not Other information related to leases was as follows (in thousands): Three Months Ended Six Months Ended Supplemental Cash Flows Information December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Cash paid for amounts included in the measurement of operating lease liabilities $ 826 $ 791 $ 1,646 $ 1,566 Operating lease liabilities arising from obtaining Right of Use Assets for new leases — — — — Operating lease liabilities arising from recording Right of Use Assets upon adoption of ASC 842 — 20,897 — 20,897 We lease substantially all of our product manufacturing and support office space used to conduct our business. For contracts entered into on or after July 1, 2019, 1 2 3 Leases are classified as either finance leases or operating leases. A lease must be classified as a finance lease if any of the following criteria are met: the lease transfers ownership of the asset by the end of the lease term, the lease contains an option to purchase the asset that is reasonably certain to be exercised, the lease term is for a major part of the remaining useful life of the asset or the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not no December 31, 2020, 6.8 3.25%. June 30, 2020, 7.2 3.24%. For all leases at the lease commencement date, a Right of Use Asset and a lease liability are recognized. The Right of Use Asset represents the right to use the leased asset for the lease term. The lease liability represents the present value of the lease payments under the lease. The Right of Use Asset is initially measured at cost, which primarily comprises the initial amount of the lease liability, plus any initial direct costs incurred, consisting mainly of brokerage commissions, less any lease incentives received. All Right of Use Assets are reviewed for impairment. The lease liability is initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, our secured incremental borrowing rate for the same term as the underlying lease. For our real estate and other operating leases, we use our secured incremental borrowing rate. Lease payments included in the measurement of the lease liability comprise the following: the fixed noncancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not Some of our manufacturing leases contain variable lease payments, including payments based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and separated into lease and non-lease components based on the initial amount stated in the lease or standalone selling prices. Lease components are included in the measurement of the initial lease liability. Additional payments based on the change in an index or rate, or payments based on a change in our portion of the operating expenses, including real estate taxes and insurance, are recorded as a period expense when incurred. Lease modifications result in remeasurement of the lease liability. Lease expense for operating leases consists of the lease payments plus any initial direct costs, primarily brokerage commissions, and is recognized on a straight-line basis over the lease term. Included in lease expense are any variable lease payments incurred in the period that were not We have elected not 12 not

Note F - Debt

Note F - Debt	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	F . Debt On July 1, 2019, February 1, 2021, November 1, 2022. $10.0 may no Under the terms of the Credit Agreement, borrowings are subject to eligibility requirements including maintaining (i) a ratio of total liabilities to tangible net worth of not 1.25 1.0 not 1.75 1.0 $100,000 1.25% one 1.25% first may may $100,000, six December 31, 2020, Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. We also have credit approval with Wells Fargo Bank, N.A. which allows us to hedge foreign currency exposures up to 30 24 In light of the global economic uncertainty related to COVID- 19 $10 June 30, 2020. not 19 $10.0 December 31, 2020, not On February 2, 2021 $10.0 zero $10.0

Note G - Economic Dependency

Note G - Economic Dependency	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	G . Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in (i) sales to these customers, (ii) the growth rate of sales to these customers, or (iii) these customers' ability to make payments when due, each individually could have a material adverse impact on our net sales and net income. Net sales to any one 10% Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Customer 1 $ 24,827 $ 12,422 $ 48,785 $ 26,776 Customer 2 8,910 5,539 11,716 9,509 $ 33,737 $ 17,961 $ 60,501 $ 36,285 We buy certain products, including beta-alanine, from a limited number of raw material suppliers who meet our quality standards. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Supplier 1 $ 6,412 1,734 $ 9,787 3,227 $ 6,412 1,734 $ 9,787 3,227 Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to receivables is concentrated with two 59.0% December 31, 2020 65.7% June 30, 2020. December 31, 2020 June 30, 2020, $3.3 100% not 4.5% December 31, 2020, 2.5% June 30, 2020.

Note H - Segment Information

Note H - Segment Information	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	H . Segment Information Our business consists of two two We evaluate performance of these segments based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before the allocation of certain corporate level expenses. Operating income or loss for each segment does not not not 2020 Our operating results by business segment were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Net Sales Private label contract manufacturing $ 45,326 $ 24,831 $ 82,373 $ 50,841 Patent and trademark licensing 2,757 4,272 5,436 7,457 Total Net Sales $ 48,083 $ 29,103 $ 87,809 $ 58,298 Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Income from Operations Private label contract manufacturing $ 6,843 $ 1,697 $ 10,270 $ 3,312 Patent and trademark licensing 529 842 1,199 1,054 Income from operations of reportable segments 7,372 2,539 11,469 4,366 Corporate expenses not allocated to segments (1,980 ) (1,841 ) (3,992 ) (3,723 ) Total Income from Operations $ 5,392 $ 698 $ 7,477 $ 643 Dec ember 31, 2020 June 30, 2020 Total Assets Private-label contract manufacturing $ 104,072 $ 100,094 Patent and trademark licensing 21,447 20,109 $ 125,519 $ 120,203 Our private-label contract manufacturing products are sold both in the U.S. and in markets outside the U.S., including Europe, Canada, Australia, New Zealand, and Asia. Our primary markets outside the U.S. are Europe and Asia. Our patent and trademark licensing activities are primarily based in the U.S. Net sales by geographic region, based on the customers' location, were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 United States $ 23,074 $ 17,591 $ 42,860 $ 35,776 Markets outside of the United States 25,009 11,512 44,949 22,522 Total $ 48,083 $ 29,103 $ 87,809 $ 58,298 Products manufactured by our Swiss subsidiary ("NAIE") accounted for 83% three December 31, 2020 85% six December 31, 2020. 91% three December 31, 2019 90% six December 31, 2019. No three six December 31, 2020 2019. Long-lived assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): December 31, 20 20 June 30, 20 20 United States $ 21,313 $ 21,769 Europe 18,130 18,108 Total Long-Lived Assets $ 39,443 $ 39,877 Total assets by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Dec ember 3 1 , 20 20 June 30, 20 20 United States $ 72,868 $ 66,489 Europe 52,651 53,714 Total Assets $ 125,519 $ 120,203 Capital expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Six Months Ended December 31, 2020 December 31, 2019 United States $ 1,033 $ 578 Europe 2,001 1,055 Total Capital Expenditures $ 3,034 $ 1,633

Note I - Income Taxes

Note I - Income Taxes	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Income Tax Disclosure [Text Block]	I . Income Taxes Our effective tax rate for the three December 31, 2020 20.8% six December 31, 2020 7.2%. six December 31, 2020, 2021 21% three December 31, 2019 17.0% six December 31, 2019 17.8%. To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 five June 30, 2020 On July 23, 2020, September 21, 2020 may 18.9%. 18.9% June 30, 2020. 2020 six December 31, 2020 2020 $0.4 2020 2015, $0.3 six December 31, 2020. six December 31, 2020 $0.4 $0.5 We had no three December 31, 2020, three six December 31, 2019. We record valuation allowances to reduce our deferred tax assets to an amount we believe is more likely than not not three six December 31, 2020, no Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates for each of the jurisdictions in which we operate. Deferred tax assets and liabilities are expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled using the tax rates then in effect. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date for such new rates. We are subject to taxation in Switzerland and in the U.S. at the federal level and in various state jurisdictions. Our tax years for the fiscal year ended June 30, 2017 June 30, 2007 June 30, 2019 It is our policy to establish reserves based on management's assessment of exposure for certain positions taken in previously filed tax returns that may no three six December 31, 2020.

Note J - Treasury Stock

Note J - Treasury Stock	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Treasury Stock [Text Block]	J . Treasury Stock On September 18, 2020, $2.0 $12.0 may, During the three December 31, 2020 175,123 $9.72 $1.7 six December 31, 2020 410,513 $8.38 $3.4 three six December 31, 2020, 30,442 three December 31, 2019 150,307 $8.33 $1.3 six December 31, 2019 151,338 $8.33 $1.3 During the three December 31, 2020, 7,744 $7.40 $57,000. six December 31, 2020, 8,436 $7.34 $62,000. three December 31, 2019 7,644 $8.67 $66,000. six December 31, 2019, 8,330 $8.74 $73,000.

Note K - Derivatives and Hedgin

Note K - Derivatives and Hedging	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	K . Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales and expenditures denominated in foreign currencies and to other transactions of NAIE, our foreign subsidiary. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we may no As of December 31, 2020, August 2022. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as interest income or expense. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. No three six December 31, 2020 December 31, 2019. We monitor the probability of forecasted transactions as part of the hedge effectiveness testing on a quarterly basis. During the three six December 31, 2020 December 31, 2019, not For foreign currency contracts not three December 31, 2020 As of December 31, 2020, $53.5 46.5 December 31, 2020, $3.0 $2.5 12 As of December 31, 2020, not $6.6 5.8 As of December 31, 2020, $3.2 $0.4 three December 31, 2020, $1.9 $0.7 six December 31, 2020, $3.9 $1.3 June 30, 2020, $0.5 $0.2 three December 31, 2019, $0.4 $0.8 six December 31, 2019, $0.9 $1.6 $54,000

Note L - Contingencies

Note L - Contingencies	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	L . Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may may not not

Note M - Subsequent Event

Note M - Subsequent Event	6 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	M. Subsequent Event On February 2, 2021 $10.0 zero $10.0

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements We did not three six December 31, 2020. Recently Issued Accounting and Regulatory Pronouncements In November 2020, No. 33 10825, 101, 103, 105, Other recently issued accounting pronouncements are not not not
Earnings Per Share, Policy [Policy Text Block]	Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options and unvested restricted shares account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2020 2019 2020 2019 Numerator Net income $ 3,632 $ 476 $ 5,890 $ 572 Denominator Basic weighted average common shares outstanding 6,270 6,795 6,344 6,818 Dilutive effect of stock options and restricted stock 135 91 94 117 Diluted weighted average common shares outstanding 6,405 6,886 6,438 6,935 Basic net income per common share $ 0.58 $ 0.07 $ 0.93 $ 0.08 Diluted net income per common share $ 0.57 $ 0.07 $ 0.91 $ 0.08 We did not three December 31, 2020. six December 31, 2020 90,000 116,658 not three six December 31, 2019 none
Revenue [Policy Text Block]	Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that each of our performance obligations is fulfilled, and control of ordered products is transferred to the customer. This transfer occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will continue to take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price of customer contracts. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2020, no We have an Exclusive Manufacturing Agreement with Juice Plus+, as amended and restated on March 31, 2019, ( 24 August 6, 2025. $0.4 three December 31, 2020 $0.8 six December 31, 2020. $0.4 three December 31, 2019 $0.8 six December 31, 2019. We currently own certain U.S. patents, and each such patent's corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as “beta-alanine”, which we market and sell under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $2.8 three December 31, 2020 $5.4 six December 31, 2020. $4.3 three December 31, 2019 $7.5 six December 31, 2019. $0.1 three December 31, 2020 $0.3 six December 31, 2020. $0.2 three December 31, 2019 $0.4 six December 31, 2019.
Share-based Payment Arrangement [Policy Text Block]	Stock-Based Compensation We had an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 October 15, 2019. January 1, 2021 ( “2020 December 4, 2020. 2020 may We did not three six December 31, 2020 December 31, 2019. three six December 31, 2020, 100,000 30,442 No three six December 31, 2019. no three six December 31, 2020 December 31, 2019. We did not three six December 31, 2020. three six December 31, 2019, 5,000 No three six December 31, 2020. three December 31, 2019, no six December 31, 2019, 15,000 $0.3 three December 31, 2020 $0.7 six December 31, 2020. $0.5 three December 31, 2019, $0.9 six December 31, 2019.
Compensation Related Costs, Policy [Policy Text Block]	Deferred Compensation Plan Effective July 16, 2020, may The Incentive Plan authorizes the Human Resources Committee or the Board of Directors to grant to, and administer, unsecured and deferred cash Awards to Participants and to subject each Award to whatever conditions are determined appropriate by the Human Resources Committee or the Board of Directors. The terms of each Award, including the amount and any conditions that must be met to be entitled to payment of the Award are set forth in an Award Agreement between each Participant and NAI. The Incentive Plan provides the Board of Directors with the discretion to set aside assets to fund the Incentive Plan although that has not On July 16, 2020, $1.0 three one two three no
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments Except for cash and cash equivalents, as of December 31, 2020 June 30, 2020, not 1. We classify derivative forward exchange contracts as Level 2 December 31, 2020 $3.6 third We also classify our outstanding line of credit balance as a Level 2 December 31, 2020, June 30, 2020, not 3. We did not three six December 31, 2020 three six December 31, 2019.
COVID-19 Pandemic [Policy Text Block]	COVID- 19 We continue to monitor and evaluate the risks to public health and the impact on overall global business activity related to the COVID- 19 may

Note A - Basis of Presentatio_2

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended December 31, December 31, 2020 2019 2020 2019 Numerator Net income $ 3,632 $ 476 $ 5,890 $ 572 Denominator Basic weighted average common shares outstanding 6,270 6,795 6,344 6,818 Dilutive effect of stock options and restricted stock 135 91 94 117 Diluted weighted average common shares outstanding 6,405 6,886 6,438 6,935 Basic net income per common share $ 0.58 $ 0.07 $ 0.93 $ 0.08 Diluted net income per common share $ 0.57 $ 0.07 $ 0.91 $ 0.08

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Schedule of Inventory, Current [Table Text Block]	Dec ember 3 1 , 2020 June 30, 20 20 Raw materials $ 22,531 $ 20,863 Work in progress 5,000 3,447 Finished goods 7,663 4,936 Reserve (728 ) (1,274 ) $ 34,466 $ 27,972

Note C - Property and Equipme_2

Note C - Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life In Years Dec ember 3 1 , 2020 June 30, 2020 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,748 3,743 Machinery and equipment 3 – 12 36,244 33,405 Office equipment and furniture 3 – 5 5,388 5,318 Vehicles 3 255 255 Leasehold improvements 1 – 15 18,151 18,031 Total property and equipment 64,986 61,952 Less: accumulated depreciation and amortization (42,577 ) (40,429 ) Property and equipment, net $ 22,409 $ 21,523

Note D - Other Comprehensive _2

Note D - Other Comprehensive Loss (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended Six Months Ended December 31, 2020 December 31, 2020 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (888 ) $ (1,415 ) $ (2,303 ) $ (888 ) $ (295 ) $ (1,183 ) OCI/OCL before reclassifications - (1,850 ) (1,850 ) - (3,913 ) (3,913 ) Amounts reclassified from OCI - 737 737 - 1,341 1,341 Tax effect of OCI activity - 259 259 - 598 598 Net current period OCI/OCL - (854 ) (854 ) - (1,974 ) (1,974 ) Ending Balance $ (888 ) $ (2,269 ) $ (3,157 ) $ (888 ) $ (2,269 ) $ (3,157 ) Three Months Ended Six Months Ended December 31, 2019 December 31, 2019 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (565 ) $ 1,116 $ 551 $ (491 ) $ 783 $ 292 ASU 2018-02 Adjustment - - - (74 ) (54 ) (128 ) OCI/OCL before reclassifications - (369 ) (369 ) - 932 932 Amounts reclassified from OCI - (808 ) (808 ) - (1,612 ) (1,612 ) Tax effect of OCI activity - 274 274 - 164 164 Net current period OCI/OCL - (903 ) (903 ) (74 ) (570 ) (644 ) Ending Balance $ (565 ) $ 213 $ (352 ) $ (565 ) $ 213 $ (352 )

Note E - Leases (Tables)

Note E - Leases (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended Six Months Ended Supplemental Cash Flows Information December 31, 2020 December 31, 2019 December 31, 2020 December 31, 2019 Cash paid for amounts included in the measurement of operating lease liabilities $ 826 $ 791 $ 1,646 $ 1,566 Operating lease liabilities arising from obtaining Right of Use Assets for new leases — — — — Operating lease liabilities arising from recording Right of Use Assets upon adoption of ASC 842 — 20,897 — 20,897

Note G - Economic Dependency (T

Note G - Economic Dependency (Tables)	6 Months Ended
	Dec. 31, 2020
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Supplier 1 $ 6,412 1,734 $ 9,787 3,227 $ 6,412 1,734 $ 9,787 3,227
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Customer 1 $ 24,827 $ 12,422 $ 48,785 $ 26,776 Customer 2 8,910 5,539 11,716 9,509 $ 33,737 $ 17,961 $ 60,501 $ 36,285

Note H - Segment Information (T

Note H - Segment Information (Tables)	6 Months Ended
	Dec. 31, 2020
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Net Sales Private label contract manufacturing $ 45,326 $ 24,831 $ 82,373 $ 50,841 Patent and trademark licensing 2,757 4,272 5,436 7,457 Total Net Sales $ 48,083 $ 29,103 $ 87,809 $ 58,298 Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Income from Operations Private label contract manufacturing $ 6,843 $ 1,697 $ 10,270 $ 3,312 Patent and trademark licensing 529 842 1,199 1,054 Income from operations of reportable segments 7,372 2,539 11,469 4,366 Corporate expenses not allocated to segments (1,980 ) (1,841 ) (3,992 ) (3,723 ) Total Income from Operations $ 5,392 $ 698 $ 7,477 $ 643
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Dec ember 31, 2020 June 30, 2020 Total Assets Private-label contract manufacturing $ 104,072 $ 100,094 Patent and trademark licensing 21,447 20,109 $ 125,519 $ 120,203
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 United States $ 23,074 $ 17,591 $ 42,860 $ 35,776 Markets outside of the United States 25,009 11,512 44,949 22,522 Total $ 48,083 $ 29,103 $ 87,809 $ 58,298
Long-lived Assets by Geographic Areas [Table Text Block]	December 31, 20 20 June 30, 20 20 United States $ 21,313 $ 21,769 Europe 18,130 18,108 Total Long-Lived Assets $ 39,443 $ 39,877
Assets by Geographic Areas [Table Text Block]	Dec ember 3 1 , 20 20 June 30, 20 20 United States $ 72,868 $ 66,489 Europe 52,651 53,714 Total Assets $ 125,519 $ 120,203
Capital Expenditures by Geographic Areas [Table Text Block]	Six Months Ended December 31, 2020 December 31, 2019 United States $ 1,033 $ 578 Europe 2,001 1,055 Total Capital Expenditures $ 3,034 $ 1,633

Note A - Basis of Presentatio_3

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020USD ($)shares	Dec. 31, 2019USD ($)shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2019USD ($)shares	Jul. 16, 2020USD ($)	Jun. 30, 2020USD ($)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		0		0
Sales, Royalty and Licensing Revenue | $	$ 2,800	$ 4,300	$ 5,400	$ 7,500
Royalty Expense | $	$ 100	$ 200	$ 300	$ 400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares)	100,000	0	100,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)	30,442		30,442
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares)	0	0	0	0
Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount | $					$ 1,000
Deferred Compensation Arrangement with Individual, Number of Payments					3
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability), Total | $	$ 0		$ 0			$ 0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability), Total | $	0		0			$ 0
Fair Value, Inputs, Level 2 [Member]
Foreign Currency Contracts, Liability, Fair Value Disclosure | $	$ 3,600		$ 3,600
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	0	5,000		5,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)	0	0	0	15,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)			0
Share-based Payment Arrangement, Expense | $	$ 300	$ 500	$ 700	$ 900
Juice Plus + [Member]
Sales Discounts, Cash | $	$ 400	$ 400	$ 800	$ 800
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			90,000
Restricted Stock 1 [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			116,658

Note A - Basis of Presentatio_4

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Numerator
Net income	$ 3,632	$ 476	$ 5,890	$ 572
Denominator
Basic weighted average common shares outstanding (in shares)	6,270,419	6,795,269	6,344,256	6,818,249
Dilutive effect of stock options and restricted stock (in shares)	135,000	91,000	94,000	117,000
Diluted weighted average common shares outstanding (in shares)	6,405,308	6,885,934	6,438,143	6,935,580
Basic net income per common share (in dollars per share)	$ 0.58	$ 0.07	$ 0.93	$ 0.08
Diluted net income per common share (in dollars per share)	$ 0.57	$ 0.07	$ 0.91	$ 0.08

Note B - Inventories, Net (Deta

Note B - Inventories, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Jun. 30, 2020
Inventory Valuation Reserves, Ending Balance	$ 728	$ 728	$ 1,274
Kaged Muscle LLC [Member]
Inventory Valuation Reserves, Ending Balance	500	500	$ 1,000
SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease), Total	$ (300)	$ (500)

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Raw materials	$ 22,531	$ 20,863
Work in progress	5,000	3,447
Finished goods	7,663	4,936
Reserve	(728)	(1,274)
Inventories, net	$ 34,466	$ 27,972

Note C - Property and Equipme_3

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Jun. 30, 2020
Property and equipment, gross	$ 64,986	$ 61,952
Less: accumulated depreciation and amortization	(42,577)	(40,429)
Property and equipment, net	22,409	21,523
Land [Member]
Property and equipment, gross	1,200	1,200
Building and Building Improvements [Member]
Property and equipment, gross	$ 3,748	3,743
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 36,244	33,405
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 5,388	5,318
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Property and equipment, gross	$ 255	255
Depreciable Life In Years (Year)	3 years
Leasehold Improvements [Member]
Property and equipment, gross	$ 18,151	$ 18,031
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Other Comprehensive _3

Note D - Other Comprehensive Loss (Details Textual) $ in Millions	6 Months Ended
	Dec. 31, 2019USD ($)
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect
Accounting Standards Update 2018-02 [Member]
Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect	$ 0.1

Note D - Other Comprehensive _4

Note D - Other Comprehensive Loss - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Balance	$ 71,131	$ 77,405	$ 71,375	$ 76,084
Balance	72,488	76,120	72,488	76,120
ASU 2018-02 Adjustment
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Balance	(888)	(565)	(888)	(491)
OCI/OCL before reclassifications
Amounts reclassified from OCI
Tax effect of OCI activity
Net current period OCI/OCL				(74)
Balance	(888)	(565)	(888)	(565)
ASU 2018-02 Adjustment				(74)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Balance	(1,415)	1,116	(295)	783
OCI/OCL before reclassifications	(1,850)	(369)	(3,913)	932
Amounts reclassified from OCI	737	(808)	1,341	(1,612)
Tax effect of OCI activity	259	274	598	164
Net current period OCI/OCL	(854)	(903)	(1,974)	(570)
Balance	(2,269)	213	(2,269)	213
ASU 2018-02 Adjustment				(54)
AOCI Attributable to Parent [Member]
Balance	(2,303)	551	(1,183)	292
OCI/OCL before reclassifications	(1,850)	(369)	(3,913)	932
Amounts reclassified from OCI	737	(808)	1,341	(1,612)
Tax effect of OCI activity	259	274	598	164
Net current period OCI/OCL	(854)	(903)	(1,974)	(644)
Balance	$ (3,157)	(352)	$ (3,157)	(352)
ASU 2018-02 Adjustment				$ (128)

Note E - Leases (Details Textua

Note E - Leases (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Jul. 01, 2019
Operating Lease, Right-of-Use Asset	$ 17,034	$ 18,354
Operating Lease, Weighted Average Remaining Lease Term (Year)	6 years 292 days	7 years 73 days
Operating Lease, Weighted Average Discount Rate, Percent	3.25%	3.24%
Accounting Standards Update 2016-02 [Member]
Operating Lease, Right-of-Use Asset			$ 20,700
Operating Lease, Liability, Total			$ 20,900

Note E - Leases - Lease Cash Fl

Note E - Leases - Lease Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Cash paid for amounts included in the measurement of operating lease liabilities	$ 826	$ 791	$ 1,646	$ 1,566
Operating lease liabilities arising from obtaining Right of Use Assets for new leases
Operating lease liabilities arising from recording Right of Use Assets upon adoption of ASC 842		$ 20,897		$ 20,897

Note F - Debt (Details Textual)

Note F - Debt (Details Textual) - USD ($)	Feb. 02, 2021	Jul. 01, 2019	Jun. 30, 2020	Dec. 31, 2020
Proceeds from Long-term Lines of Credit			$ 10,000,000
Line of Credit Facility, Remaining Borrowing Capacity				$ 0
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 10,000,000
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount		100,000
Minimum Prepayment Amount Under Line of Credit		$ 100,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Subsequent Event [Member]
Line of Credit Facility, Remaining Borrowing Capacity	$ 10,000,000
Repayments of Lines of Credit	10,000,000
Long-term Line of Credit, Total	$ 0
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate		1.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing		1.25%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital		1.25
Ratio of Total Current Assets to Total Current Liabilities		1.75

Note G - Economic Dependency (D

Note G - Economic Dependency (Details Textual) $ in Millions	6 Months Ended	12 Months Ended
	Dec. 31, 2020USD ($)	Jun. 30, 2020USD ($)
Kaged Muscle LLC [Member] | Notes Receivable [Member]
Accounts Receivable, after Allowance for Credit Loss, Total	$ 3.3	$ 3.3
Product Concentration Risk [Member] | Accounts Receivable [Member]
Number of Major Customers	2	2
Concentration Risk, Percentage	59.00%	65.70%
Product Concentration Risk [Member] | Accounts Receivable [Member] | Beta-alanine Raw Material [Member]
Concentration Risk, Percentage	4.50%	2.50%

Note G - Economic Dependency -

Note G - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net sales	$ 48,083	$ 29,103	$ 87,809	$ 58,298
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Net sales	33,737	17,961	60,501	36,285
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 1 [Member]
Net sales	24,827	12,422	48,785	26,776
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer 2 [Member]
Net sales	$ 8,910	$ 5,539	$ 11,716	$ 9,509

Note G - Economic Dependency _2

Note G - Economic Dependency - Substantial Net Purchase From Certain Suppliers (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Raw Material Purchases by Supplier	$ 6,412	$ 1,734	$ 9,787	$ 3,227
Supplier 1 [Member]
Raw Material Purchases by Supplier	$ 6,412	$ 1,734	$ 9,787	$ 3,227

Note H - Segment Information (D

Note H - Segment Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Number of Reportable Segments			2
Revenue from Contract with Customer, Including Assessed Tax	$ 48,083	$ 29,103	$ 87,809	$ 58,298
Non-US [Member]
Revenue from Contract with Customer, Including Assessed Tax	25,009	11,512	44,949	22,522
UNITED STATES
Revenue from Contract with Customer, Including Assessed Tax	$ 23,074	$ 17,591	$ 42,860	$ 35,776
Products Manufactured by NAIE [Member] | Non-US [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage	83.00%	91.00%	85.00%	90.00%
Products Manufactured by NAIE [Member] | UNITED STATES
Revenue from Contract with Customer, Including Assessed Tax	$ 0	$ 0	$ 0	$ 0

Note H - Segment Information -

Note H - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net sales	$ 48,083	$ 29,103	$ 87,809	$ 58,298
Income from operations	5,392	698	7,477	643
Operating Segments [Member]
Income from operations	7,372	2,539	11,469	4,366
Corporate, Non-Segment [Member]
Income from operations	(1,980)	(1,841)	(3,992)	(3,723)
Private Label Contract Manufacturing [Member]
Net sales	45,326	24,831	82,373	50,841
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from operations	6,843	1,697	10,270	3,312
Patent and Trademark Licensing [Member]
Net sales	2,757	4,272	5,436	7,457
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from operations	$ 529	$ 842	$ 1,199	$ 1,054

Note H - Segment Information _2

Note H - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Assets	$ 125,519	$ 120,203
Private Label Contract Manufacturing [Member]
Assets	104,072	100,094
Patent and Trademark Licensing [Member]
Assets	$ 21,447	$ 20,109

Note H - Segment Information _3

Note H - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Net sales	$ 48,083	$ 29,103	$ 87,809	$ 58,298
UNITED STATES
Net sales	23,074	17,591	42,860	35,776
Non-US [Member]
Net sales	$ 25,009	$ 11,512	$ 44,949	$ 22,522

Note H - Segment Information _4

Note H - Segment Information - Long-lived Assets by Geographical Region (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Long-Lived Assets	$ 39,443	$ 39,877
UNITED STATES
Long-Lived Assets	21,313	21,769
Europe [Member]
Long-Lived Assets	$ 18,130	$ 18,108

Note H - Segment Information _5

Note H - Segment Information - Total Assets by Geographical Region (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Total Assets	$ 125,519	$ 120,203
UNITED STATES
Total Assets	72,868	66,489
Europe [Member]
Total Assets	$ 52,651	$ 53,714

Note H - Segment Information _6

Note H - Segment Information - Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Capital Expenditures	$ 3,034	$ 1,633	$ 3,034	$ 1,633
UNITED STATES
Capital Expenditures	1,033	578
Europe [Member]
Capital Expenditures	$ 2,001	$ 1,055

Note I - Income Taxes (Details

Note I - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent, Total	20.80%	17.00%	7.20%	17.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			21.00%
Effective Income Tax Rate Reconciliation, Global Intangible Low-taxed Income, Amount			$ 400
Income Tax Benefit Cares Act			300
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount			400
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability			500
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 0		$ 0
Domestic Tax Authority [Member]
Open Tax Year			2017 2018 2019 2020
State and Local Jurisdiction [Member]
Open Tax Year			2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Foreign Tax Authority [Member] | Swiss Federal Tax Administration (FTA) [Member]
Open Tax Year			2019 2020

Note J - Treasury Stock (Detail

Note J - Treasury Stock (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Sep. 18, 2020
Treasury Stock, Value, Acquired, Cost Method	$ 1,758,000	$ 1,317,000	$ 3,501,000	$ 1,332,000
Stock Repurchase Plan [Member]
Stock Repurchase Program, Additional Amount Authorized					$ 2,000,000
Stock Repurchase Program, Authorized Amount					$ 12,000,000
Treasury Stock, Shares, Acquired (in shares)	175,123	150,307	410,513	151,338
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)	$ 9.72	$ 8.33	$ 8.38	$ 8.33
Treasury Stock, Value, Acquired, Cost Method	$ 1,700,000	$ 1,300,000	$ 3,400,000	$ 1,300,000
Stock Repurchase Plan [Member] | Employees and Directors [Member]
Treasury Stock, Shares, Acquired (in shares)	30,442		30,442
Stock Repurchase Plan In Connection With Restricted Stock [Member]
Treasury Stock, Shares, Acquired (in shares)	7,744	7,644	8,436	8,330
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)	$ 7.40	$ 8.67	$ 7.34	$ 8.74
Treasury Stock, Value, Acquired, Cost Method	$ 57,000	$ 66,000	$ 62,000	$ 73,000

Note K - Derivatives and Hedg_2

Note K - Derivatives and Hedging (Details Textual) € in Millions, SFr in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020EUR (€)	Dec. 31, 2020CHF (SFr)	Jun. 30, 2020USD ($)
Accumulated Other Comprehensive Income (Loss) Cumulative Cash Flow Hedges, Gain (Loss)	$ 3,000,000		$ 3,000,000
Prepaid Expenses and Other Current Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	3,200,000		3,200,000
Other Noncurrent Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	400,000		400,000
Other Current Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value							$ 500,000
Other Noncurrent Liabilities [Member]
Cash Flow Hedge Derivative Instrument Liabilities at Fair Value							$ 200,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	2,500,000		2,500,000
Cash Flow Hedging [Member]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	(1,900,000)	$ (400,000)	(3,900,000)	$ 900,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Interest Income, Effective Portion, Net	(700,000)	$ 800,000	(1,300,000)	1,600,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total				$ 54,000
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative, Notional Amount	6,600,000		6,600,000			SFr 5.8
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]
Derivative, Notional Amount	$ 53,500,000		$ 53,500,000		€ 46.5

Note M - Subsequent Event (Deta

Note M - Subsequent Event (Details Textual) - USD ($)	Feb. 02, 2021	Dec. 31, 2020
Line of Credit Facility, Remaining Borrowing Capacity		$ 0
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Subsequent Event [Member]
Repayments of Lines of Credit	$ 10,000,000
Long-term Line of Credit, Total	0
Line of Credit Facility, Remaining Borrowing Capacity	$ 10,000,000